Free tool
Stocks listed on Nasdaq GS
We cover 19 companies listed on Nasdaq GS. The median market value in the group is $66.31M. Across the group, the median move over the past trading day is −0.81%. Price change over the past year runs from −76.0% to +114.0% across the middle 80 percent of the group, with a median of −33.6%.
Other lists in this group
Table
19 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | $9.38 | +20.10% | −47.21% | −24.05% |
| CVRX | CVRx, Inc. | $3.27 | −33.94% | −53.94% | −56.75% |
| GOSS | Gossamer Bio, Inc. | $0.17 | −15.17% | −93.96% | −92.93% |
| DH | Definitive Healthcare Corp. | $0.79 | +11.75% | −66.73% | −80.44% |
| OM | Outset Medical, Inc. | $4.25 | −9.96% | +14.86% | −69.56% |
| PLRX | Pliant Therapeutics, Inc. | $1.16 | +8.41% | −7.20% | −31.36% |
| SPRO | Spero Therapeutics, Inc. | $1.22 | +2.09% | −48.09% | −38.38% |
| XBIT | XBiotech Inc. | $2.31 | +1.76% | −2.94% | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% |
| BOLD | Boundless Bio, Inc. | $2.92 | +18.02% | +138.93% | +155.70% |
| MCRB | Seres Therapeutics, Inc. | $4.76 | −0.83% | −68.58% | −74.79% |
| MGX | Metagenomi Therapeutics, Inc. | $1.22 | +0.83% | −26.95% | −34.41% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.96 | −72.36% | −72.74% | −74.90% |
| PETS | PetMed Express, Inc. | $1.79 | −10.95% | −45.76% | −43.35% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| QNCX | Quince Therapeutics, Inc. | $31.31 | +61.64% | +4.37% | +100.71% |
| NXTC | NextCure, Inc. | $5.83 | +7.56% | −56.10% | +11.37% |
| TXMD | TherapeuticsMD, Inc. | $2.28 | +10.68% | +38.18% | +103.57% |
| TRIB | Trinity Biotech plc | $9.59 | −22.97% | +1178.67% | +547.97% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.